Modeling Dopamine Neuron Degeneration in Caenorhabditis elegans

Methods in Molecular Biology

Volumn 793, Issue , 2011, Pages 129-148

  Tucci, Michelle L ^a   Harrington, Adam J ^a   Caldwell, Guy A ^a,b,c   Caldwell, Kim A ^a,b,c  

^a UNIVERSITY OF ALABAMA   (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Alpha synuclein; Caenorhabditis elegans; Dopamine; Neurodegeneration; Neurotoxicity; Parkinson s disease

Indexed keywords

ANIMALIA; CAENORHABDITIS ELEGANS; NEMATODA;

ALPHA SYNUCLEIN; NEUROTOXIN; OXIDOPAMINE;

ANIMAL; ARTICLE; CAENORHABDITIS ELEGANS; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; GENE TRANSFER; GENETICS; HUMAN; MALE; METABOLISM; MICROINJECTION; PARKINSON DISEASE; PATHOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICROINJECTIONS; NEUROTOXINS; OXIDOPAMINE; PARKINSON DISEASE;

EID: 80054737700     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-328-8_9     Document Type: Chapter

References (21)

1. Dauer W and Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909.
2. Fahn S (2003) Description of Parkinson’s disease as a clinical syndrome. Ann N Y Acad Sci 991:1–14.
3. Caldwell GA and Caldwell KA (2008) Traversing a wormhole to combat Parkinson’s disease. Dis Model Mech 1:32–6.
4. Cao S, Gelwix CC, Caldwell KA, and Caldwell GA (2005) Torsin-mediated neuroprotection from cellular stresses to dopaminergic neurons of Caenorhabditis elegans. J Neurosci 25:3801–12.
5. Nass R, Hall DH, Miller DM III, and Blakely RD (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci USA 99:3264–9.
6. Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA (2008) Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson’s disease model. Proc Natl Acad Sci USA 105:728–33.
7. Harrington AJ, Hamamichi S, Caldwell GA, and Caldwell KA (2010) C. elegans as a model organism to investigate molecular pathways involved with Parkinson’s disease. Dev Dyn 239:1282–95.
8. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302:841.
9. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–7
10. Cao P, Yuan Y, Pehek EA, Moise AR, Huang Y, et al (2010) Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans. PLoS ONE 5:e9312.
11. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, et al (2006) Alpha-synuclein blocks ER-Golgi traffic and rab1 rescues neuron loss in Parkinson’s models. Science 313:324–8.
12. Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, et al (2006) Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans. J Biol Chem 281:334–40.
13. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, and Nollen EA (2008) C. elegans model identifies modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet 4:e1000027.
14. Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, et al (2008) A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. Hum Mol Genet 17:2997–3009.
15. Wilm T, Demel P, Koop HU, Schnabel H, Schnabel R (1999) Ballistic transformation of Caenorhabditis elegans. Gene 229: 31–5.
16. Lamesch P, Milstein S, Hao T, Rosenberg J, Li N, et al (2004) C. elegans ORFeome Version 3.1: Increasing the coverage of ORFeome resources with improved gene predictions. Genome Res 14:2064–9.
17. Invitrogen Gateway Cloning (http://www. invitrogen.com/site/us/en/home/Products-and-Services/Applications/Cloning/Gateway-Cloning.html)
18. Berkowitz LA, Knight AL, Caldwell GA, and Caldwell KA (2008) Generation of stable transgenic C. elegans using microinjection. JoVE 18: pii: 833. doi: 10.3791/833
19. Mello CC, Kramer, JM, Stinchcomb D, Ambros V (1991) Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10: 3959–70.
20. Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, and Caldwell KA (2008) Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson’s disease genes. JoVE 17:pii: 835. doi: 10.3791/835.
21. Caldwell GA, Williams SN, and Caldwell KA (2006) Integrated Genomics: A discovery-based laboratory course. John Wiley & Sons, Ltd, Chichester, England:1–225.